You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

APL female patients

Showing 1 - 25 of 5,502
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pregnancy in Acute Promielocitic Leukaemia Patients Treated With

Recruiting
  • Acute Promyelocytic Leukemia
  • Pregnancy
    • Alessandria, Italy
    • +36 more
    Dec 31, 2021

    Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending

    Not yet recruiting
    • Bladder Cancer
    • APL-1202 and APL-1501 (Single ascending dose)
    • APL-1202 and APL-1501 (Multiple Ascending dose)
    • Melbourne, Victoria, Australia
      Nucleus Network Pty Ltd
    Sep 11, 2023

    Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo

    Not yet recruiting
    • Fallopian Tube Carcinosarcoma
    • +10 more
    • Bevacizumab
    • +4 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 29, 2022

    COVID, Covid-19, Coronavirus Trial in Brazil, United States (APL-9, Vehicle Control)

    Completed
    Has Results
    • COVID
    • +8 more
    • Fresno, California
    • +23 more
    Mar 21, 2022

    Systemic Lupus Erythematosus and Antiphospholipid Syndrome

    Recruiting
    • Systemic Lupus Erythematosus
    • Antiphospholipid Syndrome
      • Chicago, Illinois
      • +9 more
      Sep 8, 2022

      Acute Promyelocytic Leukemia Trial in Canada, United States (Tretinoin and Arsenic Trioxide)

      Completed
      Has Results
      • Acute Promyelocytic Leukemia
      • Tretinoin and Arsenic Trioxide
      • Los Angeles, California
      • +11 more
      Nov 2, 2021

      Leukemia Trial in Tianjin (DNR:, Ara-c)

      Completed
      Has Results
      • Leukemia
      • Tianjin, Tianjin, China
      • +1 more
      Aug 8, 2021

      Antiphospholipid Syndrome Trial in New York (Hydroxychloroquine)

      Terminated
      Has Results
      • Antiphospholipid Syndrome
      • New York, New York
        Hospital for Special Surgery
      Aug 18, 2021

      Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Pegcetacoplan, Soliris)

      Completed
      Has Results
      • Paroxysmal Nocturnal Hemoglobinuria
      • Los Angeles, California
      • +52 more
      Mar 1, 2022

      APL Trial in Shanghai (Chidamide+venetoclax)

      Active, not recruiting
      • APL
      • Shanghai, Shanghai, China
        Jiong HU
      May 30, 2023

      De Quervain Disease Trial in Cairo (Extracorporeal Shockwave therapy, Traditional physical therapy program)

      Not yet recruiting
      • De Quervain Disease
      • Extracorporeal Shockwave therapy
      • Traditional physical therapy program
      • Cairo, Egypt
        Mostafa Gomaa Mahmoud
      Mar 12, 2023

      Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)

      Recruiting
      • Acute Promyelocytic Leukemia
      • +2 more
      • Beijing, Beijing, China
        Peking University Institute of Hematology
      Apr 26, 2023

      Endotracheal Intubation Trial in Adana (Endotracheal intubation using an endotracheal tube with cuff inflated with air,

      Recruiting
      • Endotracheal Intubation
      • Endotracheal intubation using an endotracheal tube with cuff inflated with air
      • Endotracheal intubation using an endotracheal tube with cuff inflated with saline
      • Adana, Turkey
        Department of Anesthesiology, Cukurova University Faculty of Med
      Oct 16, 2023

      The Clinical Features and Pregnancy Outcomes of CTD Patients

      Recruiting
      • Connective Tissue Diseases
      • Pregnancy Related
      • Jinan, Shandong, China
        Qilu Hospital
      Sep 26, 2022

      A Prospective, Multi-center, Observational Study for Signal-C

      Not yet recruiting
      • Colorectal Cancer
      • Advanced Adenocarcinoma
      • Signal-C™
      • (no location specified)
      Sep 26, 2023

      Bioequivalence Trial in Auckland (APL-101, PLB-1001)

      Recruiting
      • Bioequivalence
      • Auckland, New Zealand
        New Zealand Clinical Research
      Jun 13, 2022

      Antiphospholipid Syndrome Trial in Turin (Belimumab)

      Recruiting
      • Antiphospholipid Syndrome
      • Turin, Piedmont, Italy
        San Giovanni Bosco Hospital
      May 20, 2022

      Hepatocellular Carcinoma, Renal Cell Carcinoma Trial in Australia, New Zealand (APL-501, APL-101, Nivolumab)

      Terminated
      • Hepatocellular Carcinoma
      • Renal Cell Carcinoma
      • APL-501
      • +2 more
      • Albury, New South Wales, Australia
      • +8 more
      May 3, 2022

      Parkinson Disease Trial in Worldwide (APL-130277)

      Completed
      • Parkinson Disease
      • Birmingham, Alabama
      • +69 more
      Nov 11, 2022

      Medically Assisted Fertilization Techniques in Systemic

      Recruiting
      • Rheumatic Diseases
      • +4 more
      • collection and analysis of treatments and procedures already performed by normal clinical practice
      • Milan, Italy
        San Raffaele Hospital
      Mar 28, 2023

      Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)

      Recruiting
      • Acute Promyelocytic Leukemia
      • Birmingham, Alabama
      • +4 more
      Jul 12, 2022

      The Acute Promyelocytic Leukaemia Asian Consortium Project

      Recruiting
      • Acute Promyelocytic Leukemia
        • Hong Kong, Hong Kong
          Department of Medicine, the University of Hong Kong, Queen Mary
        Oct 3, 2022

        Arteriovenous Fistula Maturation in Hemodialysis or Without

        Recruiting
        • Chronic Kidney Diseases
        • Data collection in medical records
        • Blood sampling
        • Brussels, Belgium
          Brugmann University Hospital
        Oct 27, 2023

        Antiphospholipid Antibodies on Thrombin Generation During

        Not yet recruiting
        • Antiphospholipid Syndrome
        • COVID-19
        • characterization of aPL
        • Nancy, France
          Virginie Dufrost
        Nov 18, 2021

        Parkinson's Disease Trial in United States (APL-130277)

        Completed
        Has Results
        • Parkinson's Disease
        • Sun City, Arizona
        • +3 more
        Jul 14, 2020